BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21150190)

  • 1. Infections in hematogical cancer patients: the contribution of systematic reviews and meta-analyses.
    Paul M; Gafter-Gvili A; Goldberg E; Yahav D
    Acta Haematol; 2011; 125(1-2):80-90. PubMed ID: 21150190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination antimicrobial treatment versus monotherapy: the contribution of meta-analyses.
    Paul M; Leibovici L
    Infect Dis Clin North Am; 2009 Jun; 23(2):277-93. PubMed ID: 19393909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodologic issues in systematic reviews and meta-analyses.
    Montori VM; Swiontkowski MF; Cook DJ
    Clin Orthop Relat Res; 2003 Aug; (413):43-54. PubMed ID: 12897595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deconstructing evidence in orthodontics: making sense of systematic reviews, randomized clinical trials, and meta-analyses.
    Rinchuse DJ; Rinchuse DJ; Kandasamy S; Ackerman MB
    World J Orthod; 2008; 9(2):167-76. PubMed ID: 18575311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Errors in the conduct of systematic reviews of pharmacological interventions for irritable bowel syndrome.
    Ford AC; Guyatt GH; Talley NJ; Moayyedi P
    Am J Gastroenterol; 2010 Feb; 105(2):280-8. PubMed ID: 19920807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis and treatment of bacterial infections: do we need new strategies?
    Micozzi A; Bucaneve G
    Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating patient exclusion bias in meta-analysis.
    Tierney JF; Stewart LA
    Int J Epidemiol; 2005 Feb; 34(1):79-87. PubMed ID: 15561753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to read and understand and use systematic reviews and meta-analyses.
    Leucht S; Kissling W; Davis JM
    Acta Psychiatr Scand; 2009 Jun; 119(6):443-50. PubMed ID: 19469725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A; Prentice AG
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of myeloid colony-stimulating factors in hematologic malignancies: the role of systematic reviews and meta-analyses.
    Gurion R; Shacham-Abulafia A; Shpilberg O; Raanani P
    Acta Haematol; 2011; 125(1-2):68-79. PubMed ID: 21150189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic reviews and meta-analyses: an illustrated, step-by-step guide.
    Pai M; McCulloch M; Gorman JD; Pai N; Enanoria W; Kennedy G; Tharyan P; Colford JM
    Natl Med J India; 2004; 17(2):86-95. PubMed ID: 15141602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to use a systematic literature review and meta-analysis.
    Tseng TY; Dahm P; Poolman RW; Preminger GM; Canales BJ; Montori VM
    J Urol; 2008 Oct; 180(4):1249-56. PubMed ID: 18707741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based practice: how to perform and use systematic reviews for clinical decision-making.
    Kranke P
    Eur J Anaesthesiol; 2010 Sep; 27(9):763-72. PubMed ID: 20523217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic reviews and meta-analyses in infectious diseases: how are they done and what are their strengths and limitations?
    Leibovici L; Falagas ME
    Infect Dis Clin North Am; 2009 Jun; 23(2):181-94. PubMed ID: 19393904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primer: strengths and weaknesses of meta-analysis.
    Finckh A; Tramèr MR
    Nat Clin Pract Rheumatol; 2008 Mar; 4(3):146-52. PubMed ID: 18227829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
    Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
    J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cautionary tales in the interpretation of systematic reviews of therapy trials.
    Scott I; Greenberg P; Poole P; Campbell D
    Intern Med J; 2006 Sep; 36(9):587-99. PubMed ID: 16911551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic reviews and meta-analyses in the Journal of Antimicrobial Chemotherapy.
    Leibovici L; Reeves D
    J Antimicrob Chemother; 2005 Nov; 56(5):803-4. PubMed ID: 16166177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
    Bow EJ; Laverdière M; Lussier N; Rotstein C; Cheang MS; Ioannou S
    Cancer; 2002 Jun; 94(12):3230-46. PubMed ID: 12115356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.